Rebecka Klintenberg

534 total citations
12 papers, 312 citations indexed

About

Rebecka Klintenberg is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Rebecka Klintenberg has authored 12 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Rebecka Klintenberg's work include Neuroscience and Neuropharmacology Research (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Alzheimer's disease research and treatments (2 papers). Rebecka Klintenberg is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Alzheimer's disease research and treatments (2 papers). Rebecka Klintenberg collaborates with scholars based in Sweden, United States and United Kingdom. Rebecka Klintenberg's co-authors include John E. Casida, Gary B. Quistad, Per E. Andrén, Pierluigi Caboni, Lars M. Gunne, Per Svenningsson, Arthur P. Chou, Marie‐Françoise Chesselet, Nigel T. Maidment and Sharon Li and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Rebecka Klintenberg

12 papers receiving 304 citations

Peers

Rebecka Klintenberg
Eugenia Bloch‐Shilderman Israel
Kosagi Sharaf Jagannatha Rao India
Margaret G. Filbert United States
Konstantinos Kanavouras Greece
Fabrizio Ecca Italy
Brad A. Hobson United States
Shirley X. Guo‐Ross United States
Arturo R. Viscomi Italy
Jimena García Spain
Anna Hrabovská Slovakia
Eugenia Bloch‐Shilderman Israel
Rebecka Klintenberg
Citations per year, relative to Rebecka Klintenberg Rebecka Klintenberg (= 1×) peers Eugenia Bloch‐Shilderman

Countries citing papers authored by Rebecka Klintenberg

Since Specialization
Citations

This map shows the geographic impact of Rebecka Klintenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecka Klintenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecka Klintenberg more than expected).

Fields of papers citing papers by Rebecka Klintenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecka Klintenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecka Klintenberg. The network helps show where Rebecka Klintenberg may publish in the future.

Co-authorship network of co-authors of Rebecka Klintenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecka Klintenberg. A scholar is included among the top collaborators of Rebecka Klintenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecka Klintenberg. Rebecka Klintenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Nordvall, Gunnar, Ping Yan, Lotta Agholme, et al.. (2025). γ-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein/presenilin-1 mice. Journal of Pharmacology and Experimental Therapeutics. 392(4). 103400–103400. 1 indexed citations
2.
Strömberg, Kia, Susanna Eketjäll, Biljana Georgievska, et al.. (2014). Combining an amyloid‐beta (Aβ) cleaving enzyme inhibitor with a γ‐secretase modulator results in an additive reduction of Aβ production. FEBS Journal. 282(1). 65–73. 17 indexed citations
3.
Yngve, Ulrika, Kim Paulsen, Christian van der Linde, et al.. (2013). Triazolopyrimidinones as γ-secretase modulators: structure–activity relationship, modulator profile, and in vivo profiling. MedChemComm. 4(2). 422–422. 8 indexed citations
4.
Wanngren, Johanna, Santiago Parpal, Erik Portelius, et al.. (2012). Second Generation γ-Secretase Modulators Exhibit Different Modulation of Notch β and Aβ Production. Journal of Biological Chemistry. 287(39). 32640–32650. 19 indexed citations
5.
Chou, Arthur P., Nigel T. Maidment, Rebecka Klintenberg, et al.. (2008). Ziram Causes Dopaminergic Cell Damage by Inhibiting E1 Ligase of the Proteasome. Journal of Biological Chemistry. 283(50). 34696–34703. 71 indexed citations
6.
Klintenberg, Rebecka & Per E. Andrén. (2005). Altered extracellular striatal in vivo biotransformation of the opioid neuropeptide dynorphin A(1–17) in the unilateral 6‐OHDA rat model of Parkinson's disease. Journal of Mass Spectrometry. 40(2). 261–270. 27 indexed citations
7.
Quistad, Gary B., et al.. (2005). Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. Toxicology and Applied Pharmacology. 211(1). 78–83. 60 indexed citations
8.
Quistad, Gary B., Rebecka Klintenberg, & John E. Casida. (2005). Blood Acylpeptide Hydrolase Activity Is a Sensitive Marker for Exposure to Some Organophosphate Toxicants. Toxicological Sciences. 86(2). 291–299. 48 indexed citations
9.
Quistad, Gary B., Knute A. Fisher, Stewart F. Owen, Rebecka Klintenberg, & John E. Casida. (2004). Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridates. Toxicology and Applied Pharmacology. 205(2). 149–156. 15 indexed citations
10.
Klintenberg, Rebecka, et al.. (2003). Motor effects of a dopamine stabilizer (GMC1111) in primate models of Parkinson and hemiparkinsonism. European Journal of Pharmacology. 459(2-3). 231–237. 4 indexed citations
11.
Klintenberg, Rebecka, Per Svenningsson, Lars M. Gunne, & Per E. Andrén. (2002). Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism. Journal of Neural Transmission. 109(10). 1295–1307. 31 indexed citations
12.
Klintenberg, Rebecka, Lars M. Gunne, & Per E. Andrén. (2002). Tardive dyskinesia model in the common marmoset. Movement Disorders. 17(2). 360–365. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugenia Bloch‐Shilderman Breakdown of academic impact, for papers by Kosagi Sharaf Jagannatha Rao Breakdown of academic impact, for papers by Margaret G. Filbert Breakdown of academic impact, for papers by Konstantinos Kanavouras Breakdown of academic impact, for papers by Fabrizio Ecca Breakdown of academic impact, for papers by Brad A. Hobson Breakdown of academic impact, for papers by Shirley X. Guo‐Ross Breakdown of academic impact, for papers by Arturo R. Viscomi Breakdown of academic impact, for papers by Jimena García Breakdown of academic impact, for papers by Anna Hrabovská
Rankless by CCL
2026